Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) vs. RYTHM (NASDAQ:RYM) Critical Comparison

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY – Get Free Report) and RYTHM (NASDAQ:RYM – Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, valuation, risk, analyst recommendations, institutional ownership, earnings and profitability.

Volatility & Risk

Shionogi & Co., Ltd. Unsponsored ADR has a beta of 0.1, meaning that its share price is 90% less volatile than the S&P 500. Comparatively, RYTHM has a beta of 9.94, meaning that its share price is 894% more volatile than the S&P 500.

Earnings & Valuation

This table compares Shionogi & Co., Ltd. Unsponsored ADR and RYTHM”s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Shionogi & Co., Ltd. Unsponsored ADR $3.32 billion 5.13 $1.35 billion $0.90 11.12
RYTHM $70.82 million 0.38 -$33.26 million ($5.27) -2.32

Shionogi & Co., Ltd. Unsponsored ADR has higher revenue and earnings than RYTHM. RYTHM is trading at a lower price-to-earnings ratio than Shionogi & Co., Ltd. Unsponsored ADR, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Shionogi & Co., Ltd. Unsponsored ADR and RYTHM’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Shionogi & Co., Ltd. Unsponsored ADR 37.95% 14.32% 10.24%
RYTHM 9.84% 21.25% 5.51%

Insider & Institutional Ownership

1.9% of Shionogi & Co., Ltd. Unsponsored ADR shares are held by institutional investors. Comparatively, 6.0% of RYTHM shares are held by institutional investors. 3.5% of RYTHM shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Shionogi & Co., Ltd. Unsponsored ADR and RYTHM, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Shionogi & Co., Ltd. Unsponsored ADR 0 0 0 3 4.00
RYTHM 1 0 0 0 1.00

Summary

Shionogi & Co., Ltd. Unsponsored ADR beats RYTHM on 9 of the 13 factors compared between the two stocks.

About Shionogi & Co., Ltd. Unsponsored ADR

(Get Free Report)

Shionogi & Co., Ltd. is a Japan-based pharmaceutical company that researches, develops, manufactures and markets prescription medicines. Founded in Osaka in 1878, it has grown from a pharmaceutical wholesaler into a research-focused drugmaker. The company has a particular focus on infectious diseases, including HIV, influenza and COVID-19, and also works in areas such as pain and central nervous system disorders. Its products include Xofluza, an influenza treatment, and ensitrelvir, an oral COVID-19 antiviral marketed in Japan as Xocova.

About RYTHM

(Get Free Report)

I couldn’t verify a Nasdaq-listed company named RYTHM with the ticker RYM. If you mean Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), it is a biopharmaceutical company developing treatments for rare genetic diseases and other conditions linked to the brain’s melanocortin-4 receptor pathway, which helps regulate hunger and body weight. Its marketed medicine, Imcivree (setmelanotide), is approved in the United States for certain forms of rare genetic obesity and acquired hypothalamic obesity. The company is based in Boston and focuses on developing and providing therapies for patients in the United States and other markets.

Receive News & Ratings for Shionogi & Co. Ltd. Unsponsored ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shionogi & Co. Ltd. Unsponsored ADR and related companies with MarketBeat.com's FREE daily email newsletter.